Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects
Clinical trial NCT06706427 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06706427
- Sponsor
- NGGT (Suzhou) Biotechnology Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-21
- Primary completion
- 2025-11-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.